SEARCH

SEARCH BY CITATION

References

  • 1
    Hall SH, Hamil KG, French FS. Host defense proteins of the male reproductive tract. J Androl 2002; 23:58597.
  • 2
    Araki Y, Suzuki K, Matusik RJ et al. Immortalized epididymal cell lines from transgenic mice overexpressing temperature-sensitive simian virus 40 large T-antigen gene. J Androl 2002; 23:85469.
  • 3
    Chan PT, Schlegel PN. Inflammatory conditions of the male excurrent ductal system. Part II. J Androl 2002; 23:4619.
  • 4
    Hagley M. Epididymo-orchitis and epididymitis: a review of causes and management of unusual forms. Int J STD AIDS 2003; 14:3727.
  • 5
    Horner PJ. European guideline for the management of epididymo-orchitis and syndromic management of acute scrotal swelling. Int J STD AIDS 2001; 12(Suppl. 3):8893.
  • 6
    Nickel JC, Teichman JM, Gregoire M et al. Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: the Canadian PIE Study. Urology 2005; 66:93540.
  • 7
    Luzzi GA, O’Brien TS. Acute epididymitis. BJU Int 2001; 87:74755.
  • 8
    Strober W, Murray PJ, Kitani A et al. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006; 6:920.
  • 9
    Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783801.
  • 10
    Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20:197216.
  • 11
    Kufer TA, Banks DJ, Philpott DJ. Innate immune sensing of microbes by Nod proteins. Ann N Y Acad Sci 2006; 1072:1927.
  • 12
    Windheim M, Lang C, Peggie M et al. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem J 2007; 404:17990.
  • 13
    Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006; 25:66804.
  • 14
    Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol 2005; 174:445360.
  • 15
    Whitsett JA. Intrinsic and innate defenses in the lung: intersection of pathways regulating lung morphogenesis, host defense, and repair. J Clin Invest 2002; 109:5659.
  • 16
    Quayle AJ. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol 2002; 57:6179.
  • 17
    Albiger B, Dahlberg S, Henriques-Normark B et al. Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors. J Intern Med 2007; 261:51128.
  • 18
    Chaudhuri N, Whyte MK, Sabroe I. Reducing the toll of inflammatory lung disease. Chest 2007; 131:15506.
  • 19
    Wira CR, Fahey JV, Sentman CL et al. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005; 206:30635.
  • 20
    Karrasch T, Steinbrecher KA, Allard B et al. Wound-induced p38MAPK-dependent histone H3 phosphorylation correlates with increased COX-2 expression in enterocytes. J Cell Physiol 2006; 207:80915.
  • 21
    Russo MP, Bennett BL, Manning AM et al. Differential requirement for NF-kappaB-inducing kinase in the induction of NF-kappaB by IL-1beta, TNF-alpha, and Fas. Am J Physiol Cell Physiol 2002; 283:34757.
  • 22
    Jobin C, Morteau O, Han DS et al. Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology 1998; 95:53743.
  • 23
    Haller D, Russo MP, Sartor RB et al. IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. J Biol Chem 2002; 277:3816878.
  • 24
    Carmody RJ, Chen YH. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 2007; 4:3141.
  • 25
    Rosenstiel P, Fantini M, Brautigam K et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003; 124:10019.
  • 26
    Palladino MA, Johnson TA, Gupta R et al. Members of the Toll-like receptor family of innate immunity pattern-recognition receptors are abundant in the male rat reproductive tract. Biol Reprod 2007; 76:95864.
  • 27
    Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet 2005; 20:45277.
  • 28
    Zhang D, Zhang G, Hayden MS et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303:15226.
  • 29
    Dann SM, Eckmann L. Innate immune defenses in the intestinal tract. Curr Opin Gastroenterol 2007; 23:11520.
  • 30
    Heidemann J, Domschke W, Kucharzik T et al. Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense? Infect Immun 2006; 74:542532.
  • 31
    Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004; 126:105470.
  • 32
    Melmed G, Thomas LS, Lee N et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host–microbial interactions in the gut. J Immunol 2003; 170:140615.
  • 33
    Wald D, Qin J, Zhao Z et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2003; 4:9207.
  • 34
    Malm J, Nordahl EA, Bjartell A et al. Lipopolysaccharide-binding protein is produced in the epididymis and associated with spermatozoa and prostasomes. J Reprod Immunol 2005; 66:3343.
  • 35
    Harris CL, Vigar MA, Rey Nores JE et al. The lipopolysaccharide co-receptor CD14 is present and functional in seminal plasma and expressed on spermatozoa. Immunology 2001; 104:31723.
  • 36
    Schletter J, Heine H, Ulmer AJ et al. Molecular mechanisms of endotoxin activity. Arch Microbiol 1995; 164:3839.
  • 37
    Lien E, Chow JC, Hawkins LD et al. A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway. J Biol Chem 2001; 276:187380.
  • 38
    Poltorak A, Ricciardi-Castagnoli P, Citterio S et al. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci USA 2000; 97:21637.
  • 39
    Kobayashi KS, Chamaillard M, Ogura Y et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307:7314.
  • 40
    Hisamatsu T, Suzuki M, Reinecker HC et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003; 124:9931000.
  • 41
    Voss E, Wehkamp J, Wehkamp K et al. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 2006; 281:200511.
  • 42
    Takahashi Y, Isuzugawa K, Murase Y et al. Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages. J Vet Med Sci 2006; 68:4718.
  • 43
    Begue B, Dumant C, Bambou JC et al. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop. J Cell Physiol 2006; 209:24152.